|
|
Vaccine Detail
|
SYS6006 |
| Vaccine Information |
- Vaccine Name: SYS6006
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Manufacturer: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Vaccine Ontology ID: VO_0005410
- Type: mRNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Immunization Route: Intramuscular injection (i.m.)
|
| Host Response |
|
Mouse Response
- Immune Response: Two rounds of immunization with SYS6006 were able to induce the neutralizing antibodies against the SARS-CoV-2 wild-type (WT) strain, and Delta and Omicron BA.2 variants in mice or non-human primates (NHPs). A3rd round of vaccination could further enhance the titers of neutralization against Delta and Omicron variants. (Xu et al., 2023)
|
| References |
Xu et al., 2023: Ke Xu 1, Wenwen Lei 1, Bin Kang 2 3, Hanyu Yang 2 3, Yajuan Wang 2 3, Yanli Lu 2 3, Lu Lv 2 3, Yufei Sun 2 3, Jing Zhang 1, Xiaolin Wang 2 3, Mengjie Yang 1, Mo Dan 2 3, Guizhen Wu 1. A novel mRNA vaccine, SYS6006, against SARS-CoV-2. . ; ; . [PubMed: 36685587].
|
|
